Medpace
MEDP
$395.93
Share price
1.58%
Change (1 day)
100.43%
Change (1 year)
Categories
Operating Margin for Medpace (MEDP)
Operating Margin as of April 2024 (TTM): 18.96%
According to Medpace's latest financial reports and stock price the company's current Operating Margin is 18.96%. At the end of 2022 the company had an Operating Margin of 19.09%.
Operating Margin history for Medpace from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 19.09% | 9.79% |
| 2021 | 17.39% | -3.63% |
| 2020 | 18.04% | 22.05% |
| 2019 | 14.78% | 2% |
| 2018 | 14.49% | -2.01% |
| 2017 | 14.79% | 50.82% |
| 2016 | 9.81% | 81.22% |
| 2015 | 5.41% | |
| 2013 | 20.94% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.